These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7611995)

  • 41. Nicotinamide adenine dinucleotide (NAD) stimulation of DNA synthesis by human bone marrow cells.
    Schacter LP; Burke PJ
    Biochem Biophys Res Commun; 1978 Feb; 80(3):504-10. PubMed ID: 24445
    [No Abstract]   [Full Text] [Related]  

  • 42. [Research Progress in Niacinamide in the Prevention and Treatment of Mouth and Systemic Diseases].
    Lei ZX; Lin YW; Li YQ; Zhou XD
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):14-19. PubMed ID: 36647637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SUBSTITUTED NICOTINAMIDE ANALOGUES OF NICOTINAMIDE ADENINE DINUCLEOTIDE.
    WALTER P; KAPLAN NO
    J Biol Chem; 1963 Aug; 238():2823-30. PubMed ID: 14063309
    [No Abstract]   [Full Text] [Related]  

  • 44. Coenzyme analogs. II. Photochemical inactivation of reducd thionicotinamide adenine dinucleotide.
    SHIFRIN S
    Biochim Biophys Acta; 1963 Jan; 69():9-17. PubMed ID: 13977295
    [No Abstract]   [Full Text] [Related]  

  • 45. Specific coupling of nicotinamide adenine dinucleotide (NAD) to polymer supports.
    Grenner G; Schmidt H
    Z Klin Chem Klin Biochem; 1974 May; 12(5):243. PubMed ID: 4373970
    [No Abstract]   [Full Text] [Related]  

  • 46. Nicotinamide Increases Intracellular NAD
    Hsieh CL; Hsieh SY; Huang HM; Lu SL; Omori H; Zheng PX; Ho YN; Cheng YL; Lin YS; Chiang-Ni C; Tsai PJ; Wang SY; Liu CC; Noda T; Wu JJ
    Front Microbiol; 2020; 11():117. PubMed ID: 32117141
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic potential of nicotinamide adenine dinucleotide for nonalcoholic fatty liver disease.
    Gual P; Postic C
    Hepatology; 2016 Apr; 63(4):1074-7. PubMed ID: 26661503
    [No Abstract]   [Full Text] [Related]  

  • 48. UPTAKE OF NICOTINAMIDE ADENINE DINUCLEOTIDE AND EXCRETION OF ITS DEGRADATION PRODUCTS BY TISSUE CULTURE CELLS.
    SEKI S; ODA T; MATSUOKA I; SENO S
    Acta Med Okayama (1952); 1964 Oct; 18():281-95. PubMed ID: 14311539
    [No Abstract]   [Full Text] [Related]  

  • 49. Single-cell NAD(H) levels predict clonal lymphocyte expansion dynamics.
    Turner L; Van Le TN; Cross E; Queriault C; Knight M; Trihemasava K; Davis J; Schaefer P; Nguyen J; Xu J; Goldspiel B; Hall E; Rome K; Scaglione M; Eggert J; Au-Yeung B; Wallace DC; Mesaros C; Baur JA; Bailis W
    Sci Immunol; 2024 Mar; 9(93):eadj7238. PubMed ID: 38489349
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pellagra: 4 D's and 8 Points.
    Williams A
    Adv Clin Neurosci Rehabil; 2020; 20(1):fbfd9966. PubMed ID: 38125674
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting nicotinamide adenosine dinucleotide (NAD) in diffuse gliomas.
    Wu J
    Neuro Oncol; 2022 Feb; 24(2):245-246. PubMed ID: 34919142
    [No Abstract]   [Full Text] [Related]  

  • 52. Decrease in the NAD level in tumor-derived cultured fibroblasts from neurofibromatosis patients.
    Maruyama E; Shibata K; Kuramochi A; Takashima S
    Biochem Med Metab Biol; 1993 Feb; 49(1):114-5. PubMed ID: 8439446
    [No Abstract]   [Full Text] [Related]  

  • 53. Nicotinamide inhibits HIV-1 in both acute and chronic in vitro infection.
    Murray MF; Srinivasan A
    Biochem Biophys Res Commun; 1995 May; 210(3):954-9. PubMed ID: 7763268
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NAD+ Precursors: A Physiological Reboot?
    Niño-Narvión J; Camacho M; Julve J
    Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892554
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NAD
    Chen C; Yan W; Tao M; Fu Y
    Antioxidants (Basel); 2023 Jun; 12(6):. PubMed ID: 37371959
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Beyond Pellagra-Research Models and Strategies Addressing the Enduring Clinical Relevance of NAD Deficiency in Aging and Disease.
    Feuz MB; Meyer-Ficca ML; Meyer RG
    Cells; 2023 Feb; 12(3):. PubMed ID: 36766842
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emerging Role of Nicotinamide Riboside in Health and Diseases.
    Sharma C; Donu D; Cen Y
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235542
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NAD+ depletion enhances reovirus-induced oncolysis in multiple myeloma.
    Kennedy BE; Giacomantonio M; Murphy JP; Cutler S; Sadek M; Konda P; Paulo JA; Pathak GP; Renkens SHJ; Grieve S; Pol J; Gygi SP; Richardson C; Gaston D; Reiman A; Kroemer G; Elnenaei MO; Gujar SA
    Mol Ther Oncolytics; 2022 Mar; 24():695-706. PubMed ID: 35284625
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NAD
    Zheng M; Schultz MB; Sinclair DA
    Trends Immunol; 2022 Apr; 43(4):283-295. PubMed ID: 35221228
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sirtuins Modulation: A Promising Strategy for HIV-Associated Neurocognitive Impairments.
    Figarola-Centurión I; Escoto-Delgadillo M; González-Enríquez GV; Gutiérrez-Sevilla JE; Vázquez-Valls E; Torres-Mendoza BM
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.